Reduction of muscle mass mediated by myostatin in an experimental model of pulmonary emphysema;Reduccion de la masa muscular mediada por miostatina en un modeloexperimental deenfisema pulmonarReduccion de la masa muscular mediada por miostatina en un modeloexperimental de enfisema pulmonar

Archivos de Bronconeumologia

Volumn 47, Issue 12, 2011, Pages 590-598

  Fermoselle, Clara ^a,b   Sanchez, Francisco ^a,b   Barreiro, Esther ^a,b  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Myostatin; Oxidative stress; Proteolysis; Pulmonary emphysema; Reduction of muscle mass; Signaling pathways

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MYOSIN; MYOSTATIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR FKHR; ELASTASE; GLUTATHIONE PEROXIDASE; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 3; MOLECULAR MARKER; MUSCLE PROTEIN; PEROXIREDOXIN; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; ANTIOXIDANT; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE; MSTN PROTEIN, MOUSE; PANCREATIC ELASTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DOWN REGULATION; EXPERIMENTAL MODEL; GASTROCNEMIUS MUSCLE; INTRACELLULAR SIGNALING; LUNG EMPHYSEMA; MOLECULAR DYNAMICS; MOUSE; MUSCLE MASS; NONHUMAN; OXIDATIVE STRESS; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN FUNCTION; UPREGULATION; WEIGHT REDUCTION; WESTERN BLOTTING; ADULT; ANIMAL TISSUE; BODY WEIGHT; DIAPHRAGM; MALE; MUSCLE DEVELOPMENT; MUSCLE GROWTH; OXIDATION; OXIDATION REDUCTION STATE; PROTEIN BLOOD LEVEL; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; YOUNG ADULT; A J MOUSE; ANIMAL; BREATHING MUSCLE; CHEMISTRY; CYTOSOL; METABOLISM; MUSCLE ATROPHY; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

ANIMALS; ANTIOXIDANTS; CYTOSOL; DIAPHRAGM; FORKHEAD TRANSCRIPTION FACTORS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED A; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOSINS; MYOSTATIN; NF-KAPPA B; ORGAN SIZE; OXIDATIVE STRESS; PANCREATIC ELASTASE; PROTEOLYSIS; PULMONARY EMPHYSEMA; RESPIRATORY MUSCLES; WEIGHT LOSS;

EID: 84855911782     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbres.2011.07.008     Document Type: Article

References (27)

1. Swallow E.B., Reyes D., Hopkinson N.S., Man W.D., Porcher R., Cetti E.J., et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007, 62:115-120.
2. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999, 159:s1-s40. Skeletal muscle dysfunction in chronic obstructive pulmonary disease.
3. Barreiro E., Gea J., Corominas J.M., Hussain S.N.A. Nitric oxide synthases and protein oxidation in the quadriceps femoris of COPD patients. Am J Respir Cell Mol Biol 2003, 29:771-778.
4. Barreiro E., Gea J., Matar G., Hussain S.N.A. Expression and carbonylation of creatine kinase in the quadriceps femoris muscles of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2005, 33:636-642.
5. Barreiro E., de la Puente B., Minguella J., Corominas J.M., Serrano S., Hussain S.N.A., et al. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005, 171:1116-1124.
6. Barreiro E., Schols A.M., Polkey M.I., Galdiz J.B., Gosker H.R., Swallow E.B., et al. Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 2008, 63:100-107. en nombre del ENIGMA in COPD Project.
7. Marin-Corral J., Minguella J., Ramírez-Sarmiento A.L., Hussain S.N., Gea J., Barreiro E. Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients. Eur Respir J 2009, 33:1309-1319.
8. Barreiro E., Rabinovich R., Marin-Corral J., Barbera J.A., Gea J., Roca J. Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD. Thorax 2009, 64:13-19.
9. Powers S.K., Kavazis A.N., McClung J.M. Oxidative stress and disuse muscle atrophy. J Appl Physiol 2007, 102:2389-2397.
10. Ottenheijm C.A., Heunks L.M., Li Y.P., Jin B., Minnaard R., van Hees H.W., et al. Activation of the ubiquitine-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 174:997-1002.
11. Llovera M., Garcia-Martinez C., Agell N., Lopez-Soriano F.J., Argiles J.M. Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis. Int J Cancer 1995, 61:138-141.
12. Doucet M., Russell A.P., Leger B., Debigare R., Joanisse D.R., Caron M.A., et al. Muscle atrophy and hypertrophy signalling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007, 176:261-269.
13. Hussain S.N., Mofarrahi M., Sigala I., Kim H.C., Vassilakopoulos T., Maltais F., et al. Mechanical ventilation-induced diaphragm disuse in humans triggers autophagy. Am J Respir Crit Care Med 2010, 182:1377-1386.
14. Zhang X.L., Pang B.S., Hou X.L., Wang J., Wang C. Oxidative stress and peripheral skeletal muscle dysfunction in rats with emphysema. Chin Med J (Engl) 2010, 123:40-44.
15. Artaechevarria X., Blanco D., De Biurrun G., Ceresa M., Pérez-Martín D., Bastarrika G., et al. Evaluation of micro-CT for emphysema assessment in mice: Comparison with non-radiological techniques. Eur Radiol 2011, 21:954-962.
16. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
17. Diezel W., Kopperschläger G., Hofmann E. An improved procedure for protein staining in polyacrylamide gels with a new type of Coomassie Brilliant Blue. Anal Biochem 1972, 48:617-620.
18. Cai D., Frantz J.D., Tawa N.E.Jr, Melendez P.A., Oh B.C., Lidov H.G., et al. IKK/NF-B activation causes severe muscle wasting in mice. Cell 2004, 119:285-298.
19. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., et al. FoxO transcription factors induce the atrophy-related ubiquitin ligase Atrogin-1 and cause skeletal muscle atrophy. Cell 2004, 117:399-412.
20. Kamei Y., Miura S., Suzuki M., Kai Y., Mizukami J., Taniguchi T., et al. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem 2004, 279:41114-41123.
21. Shi H., Scheffler J.M., Zeng C., Pleitner J.M., Hannon K.M., Grant A.L., et al. Mitogen-activated protein kinase signaling is necessary for the maintenance of skeletal muscle mass. Am J Physiol Cell Physiol 2009, 296:C1040-C1048.
22. Zhang P., Chen X., Fan M. Signaling mechanisms involved in disuse muscle atrophy. Med Hypotheses 2007, 69:310-321.
23. Agustí A., Morlá M., Sauleda J., Saus C., Busquets X. NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 2004, 59:483-487.
24. Testelmans D., Crul T., Maes K., Agten A., Crombach M., Decramer M., et al. Atrophy and hypertrophy signalling in the diaphragm of patients with COPD. Eur Respir J 2010, 35:549-556.
25. Talmadge R.J. Myosin heavy chain isoforms expression following reduced neuromuscular activity: potential regulatory mechanisms. Muscle Nerve 2000, 23:661-679.
26. Favier F.B., Benoit H., Freyssenet D. Cellular and molecular events controlling skeletal muscle mass in response to altered use. Pflugers Arch 2008, 456:587-600.
27. Danon M.J., Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991, 14:1131-1139.